The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Ohno, Motoko ^a   Shibata, Chikako ^a   Kishikawa, Takahiro ^a   Yoshikawa, Takeshi ^a   Takata, Akemi ^a   Kojima, Kentaro ^a   Akanuma, Masao ^b   Kang, Young Jun ^c   Yoshida, Haruhiko ^a   Otsuka, Motoyuki ^a,d   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CAFFEINE; GLUCOSE; MICRORNA; MIRN103 MICRORNA, HUMAN;

ANIMAL; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ARTICLE; DRUG EFFECT;

ANIMALS; APIGENIN; CAFFEINE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; MICRORNAS; PHOSPHORYLATION;

EID: 84884175904     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02553     Document Type: Article

References (37)

1. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768-780 (2003).
2. D'Incalci, M., Steward, W. P. & Gescher, A. J. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 6, 899-904 (2005). (Pubitemid 41614802)
3. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (2006). (Pubitemid 44764104)
4. Carrington, J. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336-338 (2003). (Pubitemid 36877060)
5. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
6. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004). (Pubitemid 39265675)
7. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005). (Pubitemid 40839735)
8. Kojima, K. et al.MicroRNA122 is a key regulator of a-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2, 338 (2011).
9. Takata, A. et al. MicroRNA-140 acts as a liver tumor suppressor by controlling NF-kB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology 57, 162-170 (2013).
10. Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649-653 (2011).
11. Krützfeldt, J. et al. Silencing ofmicroRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
12. Budhraja, A. et al. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol Cancer Ther 11, 132-142 (2012).
13. Shukla, S. et al. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res 67, 6925-6935 (2007). (Pubitemid 47105540)
14. Wang, W. et al. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28, 102-110 (2000). (Pubitemid 30432478)
15. Paroo, Z., Ye, X., Chen, S. & Liu, Q. Phosphorylation of the human microRNAgenerating complex mediates MAPK/Erk signaling. Cell 139, 112-122 (2009).
16. Yi Lau, G. T. & Leung, L. K. The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines. Food Chem Toxicol 48, 3022-3027 (2010).
17. Tatsuta, A. et al. Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 18, 657-662 (2000).
18. Yin, F., Giuliano, A. E. & Van Herle, A. J. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res 19, 4297-4303 (1999).
19. Kuo, M. L. & Yang, N. C. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibitingmitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun 212, 767-775 (1995).
20. Yao, S. L. et al. Selective radiosensitization of p53-deficient cells by caffeinemediated activation of p34cdc2 kinase. Nat Med 2, 1140-1143 (1996).
21. Chan, L. P. et al. Apigenin induces apoptosis via tumor necrosis factor receptorand Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim Biophys Acta 1820, 1081-1091 (2012).
22. Mafuvadze, B., Liang, Y., Besch-Williford, C., Zhang, X. & Hyder, S. M. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Horm Cancer 3, 160-171 (2012).
23. Nicholas, C. et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 179, 7121-7127 (2007).
24. Landolfi, R., Mower, R. L. & Steiner, M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 33, 1525-1530 (1984). (Pubitemid 14105028)
25. Hsu, S. H. et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122, 2871-2883 (2012).
26. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).
27. Elmén, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008). (Pubitemid 351550859)
28. Esau, C. et al.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98 (2006).
29. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581 (2005). (Pubitemid 41266486)
30. Lindow,M. & Kauppinen, S. Discovering the first microRNA-targeted drug. J Cell Biol 199, 407-412 (2012).
31. Ku, B. M. et al. Caffeine inhibits cell proliferation and regulates PKA/GSK3b pathways in U87MG human glioma cells. Mol Cells 31, 275-279 (2011).
32. Nishizuka, T. et al. Procya nidins are potent inhibitors of LOX-1: a new player in the French Paradox. Proc Jpn Acad Ser B Phys Biol Sci 87, 104-113 (2011).
33. Teraoka, M. et al. Cytoprotective effect of chlorogenic acid against a-synucleinrelated toxicity in catecholaminergic PC12 cells. J Clin Biochem Nutr 51, 122-127 (2012).
34. Shukla, S. & Gupta, S. Apigenin: a promising molecule for cancer prevention. Pharm Res 27, 962-978 (2010).
35. Takata, A. et al. MicroRNA-22 and microRNA-140 suppress NF-kB activity by regulating the expression of NF-kB coactivators. Biochem Biophys Res Commun 411, 826-831 (2011).
36. Kubota, Y., O'Grady, P., Saito, H. & Takekawa, M. Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation. Nat Cell Biol 13, 282-291 (2011).
37. Suzuki, H. I. et al. Modulat ion of microRNA processing by p53. Nature 460, 529-533 (2009).